ArticleMolecular therapy oncolytics2023

Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing mice.

Carolin Kitzberger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.